dc.contributor.author |
Leung, Yee Fun |
en |
dc.contributor.author |
Askarian Amiri, Effat |
en |
dc.contributor.author |
Singleton, Dean |
en |
dc.contributor.author |
Ferraro-Peyret, Carole |
en |
dc.contributor.author |
Joseph, Wayne |
en |
dc.contributor.author |
Finlay, Graeme |
en |
dc.contributor.author |
Brooms, Reuben J |
en |
dc.contributor.author |
Kakadiya, Purvibahen |
en |
dc.contributor.author |
Bohlander, Stefan |
en |
dc.contributor.author |
Marshall, Elaine |
en |
dc.contributor.author |
Baguley, Bruce |
en |
dc.date.accessioned |
2019-03-05T03:25:13Z |
en |
dc.date.issued |
2018-10-12 |
en |
dc.identifier.citation |
FRONTIERS IN ONCOLOGY 8:12 pages Article number 425 12 Oct 2018 |
en |
dc.identifier.issn |
2234-943X |
en |
dc.identifier.uri |
http://hdl.handle.net/2292/45763 |
en |
dc.language |
English |
en |
dc.publisher |
FRONTIERS MEDIA SA |
en |
dc.relation.ispartofseries |
FRONTIERS IN ONCOLOGY |
en |
dc.rights |
Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. |
en |
dc.rights.uri |
https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm |
en |
dc.rights.uri |
http://creativecommons.org/licenses/by/4.0/ |
en |
dc.subject |
Science & Technology |
en |
dc.subject |
Life Sciences & Biomedicine |
en |
dc.subject |
Oncology |
en |
dc.subject |
breast cancer |
en |
dc.subject |
PI3K mTOR inhibitor BEZ235 |
en |
dc.subject |
estrogen receptor |
en |
dc.subject |
HER2 inhibitors |
en |
dc.subject |
5% and 21% oxygen |
en |
dc.subject |
CA9 |
en |
dc.subject |
ROS |
en |
dc.subject |
Triple negative breast cancer (TNBC) |
en |
dc.subject |
RECEPTOR-RELATED PROTEIN |
en |
dc.subject |
NEUROFIBROMATOSIS TYPE-1 |
en |
dc.subject |
EXPRESSION |
en |
dc.subject |
GENE |
en |
dc.subject |
NF1 |
en |
dc.subject |
SENSITIVITY |
en |
dc.subject |
DEFICIENCY |
en |
dc.subject |
RESISTANCE |
en |
dc.subject |
INHIBITORS |
en |
dc.subject |
MUTATIONS |
en |
dc.title |
Derivation of Breast Cancer Cell Lines Under Physiological (5%) Oxygen Concentrations |
en |
dc.type |
Journal Article |
en |
dc.identifier.doi |
10.3389/fonc.2018.00425 |
en |
pubs.volume |
8 |
en |
dc.rights.holder |
Copyright: The authors |
en |
pubs.author-url |
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000447130800001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=6e41486220adb198d0efde5a3b153e7d |
en |
pubs.publication-status |
Published |
en |
dc.rights.accessrights |
http://purl.org/eprint/accessRights/OpenAccess |
en |
pubs.subtype |
Article |
en |
pubs.subtype |
Journal |
en |
pubs.elements-id |
755263 |
en |
pubs.org-id |
Medical and Health Sciences |
en |
pubs.org-id |
Medical Sciences |
en |
pubs.org-id |
Auckland Cancer Research |
en |
pubs.org-id |
Molecular Medicine |
en |
pubs.org-id |
Science |
en |
pubs.org-id |
Science Research |
en |
pubs.org-id |
Maurice Wilkins Centre (2010-2014) |
en |
pubs.number |
ARTN 425 |
en |